DP
Therapeutic Areas
Premas Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oravax | COVID‑19 | Preclinical |
| Oral Insulin | Diabetes | Phase 3 |
| Anti‑Obesity Oral Drug | Obesity | Phase 1 |
| Rotavirus Vaccine | Rotavirus Infection | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Oravax | COVID‑19 | Preclinical |
| Oral Insulin | Diabetes | Phase 3 |
| Anti‑Obesity Oral Drug | Obesity | Phase 1 |
| Rotavirus Vaccine | Rotavirus Infection | Preclinical |